⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20304733 | 1.00 | — | — | |
| SCHEMBL1397125 | 0.93 | MAPT (0.32) | — | |
| SCHEMBL350172 | 0.84 | — | — | |
| SCHEMBL1397140 | 0.84 | — | — | |
| SCHEMBL545123 | 0.83 | — | — | |
| SCHEMBL17512894 | 0.81 | — | — | |
| SCHEMBL31519429 | 0.81 | — | — | |
| SCHEMBL1397143 | 0.80 | — | — | |
| SCHEMBL11070808 | 0.79 | DPP7 (0.31) | — | |
| SCHEMBL1397169 | 0.77 | MAPT (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125753-A1 | PROTECTIVE SURFACE COATINGS FOR FLOW CELLS | ILLUMINA INC (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260117218-A1 | CONTROLLED DNA FRAGMENT LENGTH BIAS FOR AMPLIFICATION | ILLUMINA INC (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260070056-A1 | FLOW CELLS WITH HYDROPHOBIC FLUID GUIDE | ILLUMINA INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260071271-A1 | FLOW CELL BONDING MATERIALS | ILLUMINA INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260035745-A1 | RESIN COMPOSITION AND FLOW CELLS INCORPORATING THE SAME | ILLUMINA INC (US) | 2026-02-05 | — | — | US | disclosed |
| US-12540354-B2 | Protective surface coatings for flow cells | ILLUMINA, INC. (US) | 2026-02-03 | — | — | US | disclosed |
| US-12523931-B2 | Flow cells | ILLUMINA, INC. (US) | 2026-01-13 | — | — | US | disclosed |
| US-20260008909-A1 | RESIN COMPOSITION AND FLOW CELLS INCORPORATING THE SAME | ILLUMINA INC (US) | 2026-01-08 | — | — | US | disclosed |
| EP-3814530-B1 | FLOW CELLS | ILLUMINA INC (US) | 2026-01-07 | — | — | EP | disclosed |
| WO-2025244914-A1 | POLISH-FREE HYDROGEL PATTERNING | ILLUMINA, INC. (US) | 2025-11-27 | — | — | WO | disclosed |
| US-7244544-B2 | Oxime derivatives and the use thereof as latent acids | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-07-17 | — | — | US | disclosed |
| WO-2006083673-A2 | PYRIDINE DERIVATIVES USEFUL AS INHIBITORS OF C-JUN N-TERMINAL KINASES | ABBOTT LABORATORIES (US) | 2006-08-10 | — | — | WO | disclosed |
| US-20060173050-A1 | Inhibitors of c-Jun N-terminal kinases | ABBVIE INC. | 2006-08-03 | — | — | US | disclosed |
| US-20060068325-A1 | Oxime derivatives and the use thereof as latent acids | YAMATO HITOSHI | 2006-03-30 | — | — | US | disclosed |
| US-6986981-B2 | Oxime derivatives and the use thereof as latent acids | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2006-01-17 | — | — | US | disclosed |
| US-20050171131-A1 | Diaminopyrimidine derivatives as growth hormone secrectgogue receptor (GHS-R) antagonists | KOSOGOF CHRISTI (US) | 2005-08-04 | — | — | US | disclosed |
| US-20050153244-A1 | Sulfonate derivatives and the use thereof as latent acids | CIBA SPECIALTY CHEMICALS CORP. | 2005-07-14 | — | — | US | disclosed |
| EP-1472576-A2 | SULFONATE DERIVATIVES AND THE USE THEROF AS LATENT ACIDS | Ciba SC Holding AG (CH) | 2004-11-03 | — | — | EP | disclosed |
| US-20040002007-A1 | Oxime derivatives and the use thereof as latent acids | CIBA SPECIALTY CHEMICALS CORP. | 2004-01-01 | — | — | US | disclosed |
| WO-2003067332-A2 | SULFONATE DERIVATIVES AND THE USE THEROF AS LATENT ACIDS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-08-14 | — | — | WO | disclosed |